Materials & Resources » Chemicals | 3-D Matrix Ltd.

3-D Matrix Ltd. | Balance Sheet

Fiscal year is May-April. All values JPY Millions.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,641
5,137
3,512
1,748
1,162
Total Accounts Receivable
-
52
89
526
45
Inventories
789
777
712
1,029
1,759
Other Current Assets
163
238
109
85
145
Total Current Assets
3,593
6,204
4,422
3,388
3,111
Net Property, Plant & Equipment
103
94
-
-
-
Total Investments and Advances
16
17
17
17
17
Intangible Assets
339
393
-
-
-
Other Assets
69
101
21
18
8
Total Assets
4,121
6,809
4,460
3,424
3,136
ST Debt & Current Portion LT Debt
813
214
214
450
450
Income Tax Payable
10
19
23
29
36
Other Current Liabilities
134
176
287
337
448
Total Current Liabilities
958
409
524
816
934
Long-Term Debt
28
14
-
-
-
Deferred Taxes
1
4
-
-
-
Total Liabilities
988
428
524
816
934
Common Equity (Total)
3,133
6,382
3,936
2,607
2,202
Total Shareholders' Equity
3,133
6,382
3,936
2,607
2,202
Total Equity
3,133
6,382
3,936
2,607
2,202
Liabilities & Shareholders' Equity
4,121
6,809
4,460
3,424
3,136

About 3-D Matrix

View Profile
Address
Kojimachi HF Building, 7/F
Tokyo Tokyo 102
Japan
Employees -
Website http://www.3d-matrix.co.jp
Updated 09/14/2018
3-D Matrix Ltd. engages in the research and development, manufacture, and sale of medical products. It operates through the Medical Products Development and Sale, and Research Reagent Sales divisions. The Medical Products Development and Sale division includes surgery based on own organization's peptide technology, regenerative medicine, medical equipment, and pharmaceutical research and development.